Physician profile
Joshua David Hahn
NPI 1558822577
$22,869.22
in general payments reported to CMS, 2019-2025
14 companies · $21K in 2025
The $21K reported for 2025 was more than what 99% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $168 · 2023: $896 · 2024: $927 · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $15K · Food and Beverage: $4,854 · Travel and Lodging: $1,707 · Education: $838.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $15,302.67 |
| Food and Beverage | $4,853.95 |
| Travel and Lodging | $1,706.58 |
| Education | $838.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $14,411.74 | 2023-2025 | Assurity, Tacticath, Ensite |
| Boston Scientific Corporation | $4,371.85 | 2023-2025 | General - Therapies, General - Brady, Emblem Mri S-Icd |
| Medtronic, INC. | $2,316.22 | 2022-2025 | Micra, Attain Command + Surevalve, Affera Mapping System |
| Biosense Webster, INC. | $786.95 | 2024-2025 | Carto 3, Nuvision Ice Catheter |
| Cardiva Medical, INC. | $333.69 | 2024-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Abiomed | $129.90 | 2023 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $119.05 | 2024-2025 | Lifevest |
| Pfizer INC. | $115.02 | 2023-2025 | |
| Astrazeneca Pharmaceuticals Lp | $87.94 | 2023-2024 | Andexxa, Wainua |
| Lantheus Medical Imaging, INC. | $61.50 | 2023-2024 | Definity |
| Amgen INC. | $57.77 | 2023-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $38.11 | 2024 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $24.06 | 2023 | Inpefa |
| Ge Healthcare | $15.42 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Hahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.